$229,462
＋7.5%
Chief Financial Officer and Chief Operating Officer
2024
$230k
40 hrs/wk
Chief Financial Officer and Chief Operating Officer at Bleeding & Clotting Disorders Institute
Fiscal year ended June 30, 2024. Published on January 25, 2026.
Total compensation
Rebecca Burns has been listed as an employee of Bleeding & Clotting Disorders Institute in Form 990 filings since fiscal year 2018. Total compensation for Rebecca Burns has increased by 78.4% from 2018 to 2024.